Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Taipei Medical University Shuang Ho Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Taiwan register with Taipei Medical University Shuang Ho Hospital as lead sponsor. Synced 17 Nov 2026
15Current trials
8Recruiting now
2Drugs in these trials
1Trial register
At a glance

Taipei Medical University Shuang Ho Hospital is the lead sponsor of 15 current clinical trials in our Taiwan register. 8 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Atorvastatin and Sodium Bicarbonate. The most-studied condition is Dementia.

ClinicalTrials.gov trials by status

  • Recruiting853%
  • Not yet open427%
  • Active, closed213%
  • By invitation17%

Trials by phase

  • Not applicable1067%
  • Observational427%
  • Phase 217%
01

Clinical trials sponsored by Taipei Medical University Shuang Ho Hospital

15 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Dance Intervention to Improve Executive Function and Physical Performance in Older Adults With Cognitive Impairment
NCT07105800 · ClinicalTrials.gov ↗ · Older Adults, Cognitive Impairment, Mild
Not applicable Recruiting 2025-11 Taiwan
Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention
NCT05407857 · ClinicalTrials.gov ↗ · Dementia
Not applicable Recruiting 2022-07 Taiwan
Investigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizophrenia
NCT07192042 · ClinicalTrials.gov ↗ · Schizophrenia and Schizophrenia Spectrum Psychosis
Observational Recruiting 2025-09 Taiwan
The Impact of Social Media-delivered Chemotherapy Side Effects Education for Breast Cancer Patients Receiving Chemotherapy
NCT06791603 · ClinicalTrials.gov ↗ · Chemotherapy Side Effects, Social Media, Education of Patients
Not applicable Recruiting 2025-01 Taiwan
Facilitating Surgical Choice in Patient With Chronic Hypertrophic Rhinitis Using a Patient Decision Aid
NCT07435714 · ClinicalTrials.gov ↗ · Allergic Rhinitis
Not applicable Recruiting 2026-03 Taiwan
Emergency Total ECLS vs Standard ACLS With ECMO Bailout for Survival in Refractory OHCA
NCT06692075 · ClinicalTrials.gov ↗ · Out-of-hospital Cardiac Arrest (OHCA)
Not applicable Recruiting 2024-11 Taiwan
Prebiotic Effects of Mulberry Fruit in Children and Adolescents With Atopic Dermatitis
NCT06636240 · ClinicalTrials.gov ↗ · Atopic Dermatitis (Eczema), Atopic Dermatitis, Probiotics
Not applicable Recruiting 2025-03 Taiwan
The Effect of Doppler Ultrasound on Calcified Tendinitis
NCT06503302 · ClinicalTrials.gov ↗ · Calcific Tendinitis of Shoulder
Not applicable Recruiting 2024-07 Taiwan
3D-Printed Mobile Phone Holder for Individuals With Upper Limb Impairments
NCT07561944 · ClinicalTrials.gov ↗ · Upper Limb Dysfunction, Hand Function Impairment, Musculoskeletal Disorders Affecting Hand Function
Observational Not yet open 2026-06 Taiwan
Aluminum Foil Reflector on Phototherapy for Newborn with Jaundice
NCT06837935 · ClinicalTrials.gov ↗ · Newborn Jaundice
Not applicable Not yet open 2025-05 Taiwan
Clinical Validation of AI-powered Smart Vehicle Assisted Gait Training in Neurodegenerative Disorders
NCT07230366 · ClinicalTrials.gov ↗ · Parkinson's Disease (PD), Dementia
Not applicable Not yet open 2026-01 Taiwan
Fall Risk Assessment in Parkinson's Disease Using Kinetikos Health
NCT07257393 · ClinicalTrials.gov ↗ · Idiopathic Parkinsonism
Observational Not yet open 2025-12 Taiwan
Atorvastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT05870007 · ClinicalTrials.gov ↗ · Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Diseases
Phase 2 By invitation 2023-05 Taiwan
Clinical Performance Evaluation of RDX-Aneurysm for Detecting Intracranial Aneurysms on TOF-MRA
NCT07655635 · ClinicalTrials.gov ↗ · Intracranial Aneurysm
Observational Active, closed 2024-07 Taiwan
Paternal Involvement in Nursing Guidance and Breastfeeding Self-Efficacy in Mothers of High-Risk Newborns
NCT07834008 · ClinicalTrials.gov ↗ · Prematurity, Low Birth Weight, Respiratory Distress Syndrome, Newborn
Not applicable Active, closed 2026-08 Taiwan

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Taipei Medical University Shuang Ho Hospital trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Taipei Medical University Shuang Ho Hospital trials

26 conditions
Dementia2Upper Limb Dysfunction1Hand Function Impairment1Musculoskeletal Disorders Affecting Hand Function1Difficulty Operating Smartphones Due to Upper Limb Impairment1Older Adults1Cognitive Impairment, Mild1Schizophrenia and Schizophrenia Spectrum Psychosis1Intracranial Aneurysm1Newborn Jaundice1Chemotherapy Side Effects1Social Media1Education of Patients1Prematurity1Low Birth Weight1Respiratory Distress Syndrome, Newborn1Neonatal Hyperbilirubinemia1Parkinson's Disease (PD)1Allergic Rhinitis1Autosomal Dominant Polycystic Kidney Disease1Chronic Kidney Diseases1Out-of-hospital Cardiac Arrest (OHCA)1Idiopathic Parkinsonism1Atopic Dermatitis (Eczema)1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Taiwan158

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Dementia

SponsorTrials
Washington University School of Medicine5
University of Southern California2
The University of Hong Kong2
LNA SANTE2
Neuromed IRCCS2
University of Oslo2
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal2
National Cheng Kung University2
IRCCS SYNLAB SDN1
Dalarna University1

Sponsors with the most current trials registered for this condition.

06

Questions about Taipei Medical University Shuang Ho Hospital trials

How many clinical trials does Taipei Medical University Shuang Ho Hospital sponsor?

Taipei Medical University Shuang Ho Hospital is the lead sponsor of 15 current trials on ClinicalTrials.gov in our Taiwan register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Taipei Medical University Shuang Ho Hospital trials recruiting?

Yes. 8 of its 15 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Taipei Medical University Shuang Ho Hospital testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Atorvastatin (1) and Sodium Bicarbonate (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.